制度・支援
指定難病 — No.335

ネフロン癆

検索語 Nephronophthisis ・ 最終更新 2026-09-17 12:12 ・ 最新に更新

Data Sheet
指定 No.335
Src PubMed · CT.gov · jRCT

これは医療アドバイスではありません。診断・治療の判断は必ず主治医にご相談ください。論文や治験は「今わかっている研究の状況」を示すもので、効果を保証するものではありません。

( 01 )EVIDENCE / PUBMED · 5件

世界の論文

直近の研究を、やさしい日本語で

各論文の見出しにある「確からしさ」は、その研究がどれくらい信頼できるかの目安です。「理論段階」はまだ仮説に近く、下にいくほど多くの患者で検証されていて、「メタ解析」がもっとも信頼できます。

症例報告
MK-01 · PMID 42734259

Phenotypic and Genotypic Landscape of Sitosterolemia in China: Including a Rare Case With Nephronophthisis

Abstract / 原文

BACKGROUND: Sitosterolemia (STSL) is a rare autosomal recessive disorder caused by mutations in ABCG5 or ABCG8, characterized by hemolytic anemia, xanthomas, and atherosclerosis. Nephronophthisis (NPHP), another autosomal recessive disorder, is characterized by its devastating progression toward renal failure. METHODS: We analyzed the clinical, laboratory, and genetic data of a Chinese boy with concurrent STSL and NPHP. Separately, we conducted a comprehensive review of the phenotypic and genotypic profiles of all previously reported STSL cases in China. RESULTS: The proband presented with recurrent fever, thrombocytopenia, splenomegaly, and renal dysfunction and was initially misdiagnosed with hemophagocytic lymphohistiocytosis. Genetic testing confirmed biallelic ABCG8 mutations (c.490C>T and c.323-1G>C) and a homozygous NPHP1 deletion. A comprehensive review of 131 Chinese STSL cases (130 from the literature) found that xanthomas, hypercholesterolemia, and elevated low-density lipoprotein cholesterol (LDL-C) were the most common manifestations (each with a prevalence of 82.4%), followed by splenomegaly (32.1%), thrombocytopenia (32.1%), and anemia (30.5%). Hypercholesterolemia and high LDL-C were more common in children, whereas hematologic abnormalities and organ damage were more prevalent in adults. Mutations in ABCG5 accounted for 77.1% of patients. CONCLUSIONS: Genetic testing is crucial when clinical findings conflict with the initial diagnosis. This study summarizes the largest cohort of Chinese STSL patients to date, which may aid in the early recognition and management of this condition.

Journal
Molecular genetics & genomic medicine(2026 Sep)
Authors
5名
Type
Journal Article, Case Reports, Review
PubMedで原文を見る
観察研究
MK-02 · PMID 42647230

Modeling Complex Developmental Disease: The Case of Polycystic Kidney Disease

Abstract / 原文

Both genetics and the environment affect the phenotypes of polycystic kidney diseases (PKD), such as autosomal dominant (AD) PKD, autosomal recessive (AR) PKD and nephronophthisis (NPH). Variable phenotypes, pleiotropy, divergent severity and progression, even in family members who inherited the same disease-causing mutation(s), signal the involvement of networked genes and modifiers. Several PKD-linked genes function in development and renal tubule morphogenesis. Cystic renal tissues feature metabolic remodeling, functional reprogramming and dysregulation of several shared factors and pathways. ADPKD, ARPKD and NPH partially phenocopy each other. Understanding the developmental arc of cystic kidney disease and its complex phenotypes would improve diagnostics and help develop effective personalized treatments. However, this is challenging to study in vertebrate systems due to genetic redundancy, functional overlap, and a dearth of genetic tools. Underused in this context, Drosophila melanogaster offers high genomic and pathway conservation, a wealth of genetic tools, and rapid generation times, making it a reliable and sustainable model for mechanistic, genome-wide, and precision medicine studies. Here, we surveyed ADPKD, ARPKD, and NPH, compared renal and extrarenal phenotypes, and examined the network of shared and unique contributors, their healthy and diseased functions and conservation from the perspective of mechanistic whole-animal modeling.

Journal
Journal of developmental biology(2026 Aug)
Authors
6名
Type
Journal Article, Review
PubMedで原文を見る
症例報告
MK-03 · PMID 42639982

Combined Liver-Kidney Transplantation in Pediatric Patients From Colombia: A Case Series

Abstract / 原文

BACKGROUND: Pediatric combined liver-kidney transplantation is uncommon, and evidence from Latin America is scarce. METHODS: We report a single-center case series of four pediatric recipients who underwent combined liver-kidney transplantation at a tertiary Latin-American center. We summarize primary indications, perioperative course, early complications, and graft function at follow-up. RESULTS: Underlying diseases were primary hyperoxaluria type I (n = 1), nephronophthisis type 3 (n = 2), and hepatorenal fibropolycystic disease/autosomal recessive polycystic kidney disease (n = 1). Early complications included bacterial and viral infections, bleeding, and acute tubular necrosis. Three biopsy-proven acute rejection episodes occurred (one moderate-severe hepatic and two renal, including one late T-cell-mediated episode); all responded to treatment. At last follow-up, all four patients were alive with functioning liver and kidney grafts. In three cases with long-term follow-up, the estimated glomerular filtration rate was 72, 64, and 48 mL/min/1.73 m2 with normal liver profiles; in one case with shorter institutional follow-up, the estimated glomerular filtration rate was 74 mL/min/1.73 m2 with a transient liver profile abnormality. CONCLUSIONS: This first pediatric series from Latin America suggests that combined liver-kidney transplantation is feasible and can achieve favorable long-term patient and graft survival when candidates are appropriately selected and infectious and rejection complications are managed in a protocolized manner.

Journal
Pediatric transplantation(2026 Aug)
Authors
9名
Type
Case Reports, Journal Article
PubMedで原文を見る
観察研究
MK-04 · PMID 42538694

Kidney Transplant in Joubert Syndrome: A Human-Centered Case Series From a Single Center

Abstract / 原文

OBJECTIVES: Joubert syndrome is a rare ciliopathy in which kidney disease can quietly progress to end -stage kidney disease, often in children and young adults. For these patients and their families, kidney transplant is a turning point, yet published experience remains limited. Here, we share our center's experience with kidney transplant in 5 patients with Joubert syndrome who progressed to end -stage kidney disease, highlighting medical outcomes and practical challenges. MATERIALS AND METHODS: We conducted a retrospective case series of 5 patients with Joubert syndrome and end -stage kidney disease who received kidney transplants at our center. We reviewed medical records for demographic data, neurological and extrarenal features, renal course, transplant details, immunosuppression, complications, and long -term graft and patient outcomes. RESULTS: The cohort included 3 male and 2 female patients who received transplants between 12 and 40 years of age. Two patients had genetically confirmed Joubert syndrome, and 3 patients had a clinical diagnosis. Nephronophthisis was the documented cause of end -stage kidney disease in 2 children, whereas 3 patients had end -stage kidney disease attributed to Joubert syndrome without further histology classification. All patients received calcineurin inhibitor -based triple immunosuppression. Delayed graft function occurred in all 5 recipients. Two patients developed biopsy -proven T -cell -mediated acute rejection, successfully treated with pulse steroids. At last follow -up, 3 patients were alive with functional grafts, 1 patient was alive on dialysis after graft loss due to chronic pyelonephritis, and 1 patient died from severe infection with a functional graft. CONCLUSIONS: Kidney transplant is feasible and generally effective in patients with Joubert syndrome, offering durable renal replacement in most cases. However, the universal occurrence of delayed graft function and the effect of infectious complications, which led to 1 graft loss and 1 death, emphasize the need for careful perioperative management, urological assessment, and close long -term follow -up within a multidisciplinary framework.

Journal
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation(2026 Jul)
Authors
8名
Type
Journal Article
PubMedで原文を見る
基礎研究(細胞・動物など)
MK-05 · PMID 42517941

Detection of the NPHP4 c.2999_3005del (p.Asn1000SerfsTer4) variant in an Iranian family with nephronophthisis-4

Abstract / 原文

Nephronophthisis type 4 (NPHP4) is a rare genetic kidney disorder progressing to end-stage renal disease (ESRD). In this study, we aimed to identify the genetic cause of NPHP4 in a pedigree with three affected individuals. Whole-exome sequencing was performed on the proband, and variants were filtered, analyzed, and evaluated using in silico tools. Co-segregation analysis was conducted using Sanger sequencing. Protein modeling for the wild-type and mutant forms was performed using AlphFold3. We identified a homozygous deletion (c.2999_3005delTGTGTGT/ p.Asn1000SerfsTer4) in exon 21 of NPHP4, which co-segregated with the disease in the pedigree, demonstrating an autosomal recessive inheritance. 3D protein modeling predicted significant structural changes due to the truncation. The results of this study reveal a deletion variant NPHP4 c.2999_3005del (p.Asn1000SerfsTer4) that causes NPHP4 disease. This study, as a second report of a variant, reaffirms this very variant's pathogenicity and illuminates a critical locus prone to disruption, enhancing our understanding of genotype-phenotype correlations in NPHP4. The concurrence of independent observations of the same variants in NPHP4 emphasizing C-terminal truncation strengthens evidence that disruption of this region is clinically relevant in NPHP4-related disease. These findings together can provide improved understanding of the genetic basis of the disease, therefore better guidance for genetic counseling and family planning strategies for additional affected families.

Journal
Molecular genetics and genomics : MGG(2026 Jul)
Authors
3名
Type
Journal Article
PubMedで原文を見る
( 02 )TRIALS / JAPAN · 0件

日本で参加できる治験

現在 募集中のもの

日本で現在募集中の治験は見つかりませんでした。下の公式レジストリで条件を変えると見つかる場合があります。
( 03 )REGISTRY / jRCT

治験をもっと探す

日本の公式レジストリで全件を確認

上の一覧は ClinicalTrials.gov の一部です。日本国内の治験の多くは、日本の公式レジストリ jRCT にのみ登録されています。下記から最新の全件を確認できます。

jRCT で検索日本の臨床研究実施計画 公開システム「対象疾患名」に ネフロン癆 を入力し、「募集状況」で 募集中 にチェックして検索します。ClinicalTrials.gov で全件を見る世界最大の治験データベース(英語)「ネフロン癆・日本・募集中」の条件で一覧が開きます。

※ jRCTは自動の大量データ取得を禁じているため、本サービスは自動収集せず、ご自身が公式サイトで検索できるリンクでご案内しています(規約順守)。

お金・介護・制度ネフロン癆の療養に使えるかもしれない公的サポートを調べる医療費・生活費・介護の支援制度と相談先を、あなたの状況に合わせてご案内(回答は端末内で完結)
( 04 )SUPPORT

患者会・相談窓口

一人で抱え込まないでください

同じ病気の患者・家族とつながる、制度や生活の相談をする、といったときの窓口です。

全国の相談先

※ お住まいの都道府県の「難病相談支援センター」でも、医療費助成や療養生活の相談ができます(難病情報センターから探せます)。